C-reactive protein–triglyceride–glucose index is an independent predictor of cardiovascular mortality in patients with metabolic syndrome
Journal of Clinical Lipidology · 2026-05 · 20 (5) · 915-925
DOI: 10.1016/j.jacl.2026.02.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2026-05. Verfasst von Sahil Ghay und 8 weiteren Autor:innen. Beteiligte Einrichtung: Semyon and Janna Friedman Advanced Research Institute at Mount Sinai Medical Center, Miami Beach, FL, USA (Ghay, Kaur, Urina-Jassir, Mihos, and T.K. …. Hauptthemen laut MEDLINE: Metabolic Syndrome, C-Reactive Protein, Cardiovascular Diseases, Blood Glucose. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Metabolic syndrome (MetS) is characterized by an interplay of risk factors mediated by chronic inflammation and is strongly linked to increased cardiovascular (CV) mortality. C-reactive protein-triglyceride-glucose index (CTI) has emerged as a marker for both insulin resistance and systemic inflammation, both established CV risk factors. This study examines whether CTI predicts CV mortality among adults with MetS. METHODS: The National Health and Nutrition Examination Survey database was queried from 1999 to 2010, and data on mortality follow-up through December 31, 2019, were analyzed. Patients with MetS were identified by stratifying individuals aged ≥20 years who met ≥3 of the 5 MetS criteria. CTI was derived using the formula 0.412 × ln(C-reactive protein [mg/L]) + ln(Triglycerides [mg/dL] × Fasting Glucose [mg/dL]/2). Cox proportional hazards models were used to assess the association between CTI and CV mortality. Restricted cubic splines assessed for nonlinearity in this association. RESULTS: A total of 10,421 patients with MetS were identified. In a fully adjusted survey-weighted model, each 1-unit increase in CTI was associated with a 32% higher risk of CV mortality (hazard ratio [HR] = 1.32; 95% CI: 1.07-1.62; P = .010). Quartile-based analysis revealed no significant association for Quartiles 2 and 3 compared with Quartile 1. However, Quartile 4 had significantly higher CV mortality (HR = 1.60; 95% CI: 1.13-2.25; P = .007). Spline analysis supported a linear relationship. CONCLUSION: Higher CTI, particularly values in the highest quartile, was independently associated with increased CV mortality in adults with MetS. These findings suggest that CTI may help identify high-risk individuals for early prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Semyon and Janna Friedman Advanced Research Institute at Mount Sinai Medical Center, Miami Beach, FL, USA (Ghay, Kaur, Urina-Jassir, Mihos, and T.K. Elajami); Division of Cardiology, Mount Sinai Medical Center, Miami Be…
- Department of Internal Medicine, Hartford Hospital, Hartford, CT, USA (M.K. Elajami).
- Section of Cardiovascular Research and Center for Cardiometabolic Disease Prevention, Department of Medicine, Baylor College of Medicine, Houston, TX, USA (Abushamat).
- Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA (Bahmad).
- Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA (Welty).
Zitieren
APA
Ghay, S., Elajami, M. K., Kaur, B., Abushamat, L. A., Urina-Jassir, D., Bahmad, H. F., Welty, F. K., Mihos, C. G., & Elajami, T. K. (2026). C-reactive protein–triglyceride–glucose index is an independent predictor of cardiovascular mortality in patients with metabolic syndrome. Journal of Clinical Lipidology, 20(5), 915-925. https://doi.org/10.1016/j.jacl.2026.02.026
Vancouver
Ghay S, Elajami MK, Kaur B, Abushamat LA, Urina-Jassir D, Bahmad HF, et al. C-reactive protein–triglyceride–glucose index is an independent predictor of cardiovascular mortality in patients with metabolic syndrome. Journal of Clinical Lipidology. 2026;20(5):915-925. doi:10.1016/j.jacl.2026.02.026
BibTeX
@article{Ghay2026,
author = {Ghay, Sahil and Elajami, Mohamad K and Kaur, Baneet and Abushamat, Layla A and Urina-Jassir, Daniela and Bahmad, Hisham F and Welty, Francine K and Mihos, Christos G and Elajami, Tarec K},
title = {C-reactive protein–triglyceride–glucose index is an independent predictor of cardiovascular mortality in patients with metabolic syndrome},
journal = {Journal of Clinical Lipidology},
year = {2026},
volume = {20},
number = {5},
pages = {915--925},
doi = {10.1016/j.jacl.2026.02.026}
}
EUVIMED